InvestSMART

PharmAust Limited (ASX: PAA) - Announcements

Current share price for PAA : $0.230 0.015 (6.98%)+

ASX company news and announcements for PharmAust Limited (PAA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All PharmAust Limited (PAA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than PharmAust Limited (PAA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for PharmAust Limited (PAA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Results of General Meeting 30 Jun 2023 12:38PM $0.075 $0.230 risen by 206.67%
- Trading Halt 30 Jun 2023 9:48AM $0.075 $0.230 risen by 206.67%
- General Meeting - Chairman Script 30 Jun 2023 9:42AM $0.075 $0.230 risen by 206.67%
- Motor Neurone Disease Phase 1/2 Clinical Trial Update 27 Jun 2023 8:17AM $0.069 $0.230 risen by 233.33%
- Commencement of Cohort 3 in Phase 1/2 MND Trial 9 Jun 2023 9:54AM $0.075 $0.230 risen by 206.67%
- PharmAust MND Trial Interim Analysis PK Outcomes 7 Jun 2023 9:31AM $0.077 $0.230 risen by 198.70%
- Trading Halt 5 Jun 2023 9:36AM $0.077 $0.230 risen by 198.70%
- Notice of General Meeting/Proxy Form 26 May 2023 1:16PM $0.076 $0.230 risen by 202.63%
- Motor Neurone Disease Clinical Trial Update 22 May 2023 9:29AM $0.082 $0.230 risen by 180.49%
- Securities issued under LR7.1 & LR7.1A 16 May 2023 11:40AM $0.082 $0.230 risen by 180.49%
- Progress update on Phase 1/2 MND interim analysis 16 May 2023 8:27AM $0.079 $0.230 risen by 191.14%
- Application for quotation of securities - PAA 11 May 2023 3:27PM $0.080 $0.230 risen by 187.50%
- Cancel - Notification regarding unquoted securities - PAA 11 May 2023 3:27PM $0.080 $0.230 risen by 187.50%
- Notification regarding unquoted securities - PAA 11 May 2023 9:32AM $0.083 $0.230 risen by 177.11%
- Terms & Conditions of Unlisted Options 11 May 2023 9:26AM $0.083 $0.230 risen by 177.11%
- Appendix 3Y 11 May 2023 9:24AM $0.083 $0.230 risen by 177.11%
- Section 708(5) Notice 11 May 2023 9:22AM $0.083 $0.230 risen by 177.11%
- Notification regarding unquoted securities - PAA 11 May 2023 9:00AM $0.083 $0.230 risen by 177.11%
- Notification regarding unquoted securities - PAA 11 May 2023 8:54AM $0.083 $0.230 risen by 177.11%
- Application for quotation of securities - PAA 11 May 2023 8:49AM $0.083 $0.230 risen by 177.11%
- Independent tests show MPL retains long-term shelf-life 10 May 2023 8:19AM $0.081 $0.230 risen by 183.95%
- MPL has anti-cancer effects across multiple cancer types 9 May 2023 8:17AM $0.081 $0.230 risen by 183.95%
- Proposed issue of securities - PAA 3 May 2023 10:09AM $0.100 $0.230 risen by 130%
- PharmAust Raises $2.5m via Placement 3 May 2023 10:09AM $0.100 $0.230 risen by 130%
- Appendix 4C and Quarterly Update 28 Apr 2023 6:27PM $0.100 $0.230 risen by 130%

176 - 200 of 796 results

Page 8 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.